Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis

Published:2018-07-15 Issue:3 Volume:50 Page:791-800
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Ji Jun Ho,Kim Young Saing,Park Inkeun,Lee Soon Il,Kim Rock Bum,Park Joon Oh,Oh Sung Yong,Hwang In Gyu,Jang Joung-Soon,Song Haa-Na,Kang Jung-Hun

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2017-044.pdf

Reference16 articles.

1. Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial.

2. Chemotherapy prolongs survival in inoperable pancreatic carcinoma

3. Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues

4. Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma;World Journal of Gastroenterology;2024-03-07

2. Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map;Clinical Epidemiology;2023-11

3. A Systematised Literature Review of Real-World Treatment Patterns and Outcomes in Unresectable Advanced or Metastatic Biliary Tract Cancer;Targeted Oncology;2023-09-26

4. Treatment patterns and survival in older adults with unresected nonmetastatic biliary tract cancers;Journal of Geriatric Oncology;2023-04

5. Short- and Long-Term Survival of Metastatic Biliary Tract Cancer in the United States From 2000 to 2018;Cancer Control;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3